Pomerantz Roger 4
4 · Viracta Therapeutics, Inc. · Filed Aug 18, 2023
Insider Transaction Report
Form 4
Pomerantz Roger
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-08-16+15,000→ 15,000 totalExercise: $1.23Exp: 2033-08-16→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]1/12th of the shares subject to the option shall vest each month following the Vesting Commencement Date (as defined below), or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date. The Vesting Commencement Date is June 9, 2023.